Non-Invasive Markers for the Diagnosis of MASLD

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, especially in patients with obesity. Here, Dr. Johanna Brix, a leading diabetologist and obesity specialist from Austria, delves into the critical role of non-invasive markers in diagnosing MASLD.

  • Pre Questionnaire
  • Video
  • Post Questionnaire
  • How much experience do you have with diagnosing MASLD in your practice?(Required)
  • This field is for validation purposes and should be left unchanged.

    • Dr. Johanna Brix
    • MASLD
    • Video views: 21
    • Rating: 7.1 out of 10

    EASO has received funding to support components of the 5-MIN CPD programme via an unrestricted grant from Boehringer-Ingelheim. Boehringer-Ingelheim had no influence over the content of any of the modules.